1. Academic Validation
  2. Allosteric Inhibitors of the SARS-COV-2 Papain-like Protease Domain Induce Proteasomal Degradation of Its Parent Protein NSP3

Allosteric Inhibitors of the SARS-COV-2 Papain-like Protease Domain Induce Proteasomal Degradation of Its Parent Protein NSP3

  • ACS Chem Biol. 2024 Jan 19;19(1):22-36. doi: 10.1021/acschembio.3c00312.
Peter E Cockram 1 2 Benjamin T Walters 3 Aaron Lictao 3 Frances Shanahan 2 Ingrid E Wertz 2 Scott A Foster 2 Joachim Rudolph 1
Affiliations

Affiliations

  • 1 Discovery Chemistry, Genentech, South San Francisco, California 94080, United States.
  • 2 Discovery Oncology, Genentech, South San Francisco, California 94080, United States.
  • 3 Biochemical and Cellular Pharmacology, Genentech, South San Francisco, California 94080, United States.
Abstract

The papain-like Protease of SARS-COV-2 is essential for viral replication and pathogenesis. Its location within a much larger multifunctional protein, NSP3, makes it an ideal candidate for a targeted degradation approach capable of eliminating multiple functions with a single-molecule treatment. In this work, we have developed a HiBiT-based cellular model to study NSP3 degradation and used this platform for the discovery of monovalent NSP3 degraders. We present previously unreported degradation activity of published papain-like Protease Inhibitors. Follow-up exploration of structure-activity relationships and mechanism-of-action studies points to the recruitment of the ubiquitin-proteasome machinery that is solely driven by site occupancy, regardless of molecular features of the ligand. Supported by HDX data, we hypothesize that binding-induced structural changes in NSP3 trigger the recruitment of an E3 Ligase and lead to proteasomal degradation.

Figures
Products